ProQR CEO Daniel Anton de Boer acquires 200,000 shares for $353,960
Reuters2026/08/03 20:01- ProQR Therapeutics CEO Daniel Anton de Boer bought 200,000 ordinary shares at $1.77, lifting direct holdings to 500,000 shares.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Extreme level of 8,500 emerges! Two top strategists raise S&P 500 target as strong earnings become key support
Despite facing a surge in US Treasury yields surpassing 5% and a slowdown in the AI sector, Wall Street institutions continue to raise their S&P 500 target prices, with the most bullish forecasts reaching up to 8,500 points.
BIG Impact invests in autoimmune diagnostics and drug discovery startup AOI Biosciences
LG Electronics Gains a Bull on Likely 3Q Earnings Beat -- Market Talk
2-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
